位置:首页 > 蛋白库 > PP16B_BOVIN
PP16B_BOVIN
ID   PP16B_BOVIN             Reviewed;         568 AA.
AC   Q95N27;
DT   13-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   03-AUG-2022, entry version 126.
DE   RecName: Full=Protein phosphatase 1 regulatory inhibitor subunit 16B;
DE   AltName: Full=CAAX box protein TIMAP;
DE   AltName: Full=TGF-beta-inhibited membrane-associated protein;
DE            Short=bTIMAP;
DE   Flags: Precursor;
GN   Name=PPP1R16B;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INDUCTION BY TGFB1, AND SUBCELLULAR LOCATION.
RX   PubMed=12055102; DOI=10.1152/ajpcell.00442.2001;
RA   Cao W., Mattagajasingh S.N., Xu H., Kim K., Fierlbeck W., Deng J.,
RA   Lowenstein C.J., Ballermann B.J.;
RT   "TIMAP, a novel CAAX box protein regulated by TGF-beta1 and expressed in
RT   endothelial cells.";
RL   Am. J. Physiol. 283:C327-C337(2002).
RN   [2]
RP   FUNCTION, PHOSPHORYLATION AT SER-333 AND SER-337, AND MUTAGENESIS OF
RP   VAL-64; PHE-66; SER-333 AND SER-337.
RX   PubMed=17609201; DOI=10.1074/jbc.m703532200;
RA   Li L., Kozlowski K., Wegner B., Rashid T., Yeung T., Holmes C.,
RA   Ballermann B.J.;
RT   "Phosphorylation of TIMAP by glycogen synthase kinase-3beta activates its
RT   associated protein phosphatase 1.";
RL   J. Biol. Chem. 282:25960-25969(2007).
RN   [3]
RP   INDUCTION BY LPS.
RX   PubMed=21907835; DOI=10.1016/j.resp.2011.08.012;
RA   Poirier C., Gorshkov B.A., Zemskova M.A., Bogatcheva N.V., Verin A.D.;
RT   "TIMAP protects endothelial barrier from LPS-induced vascular leakage and
RT   is down-regulated by LPS.";
RL   Respir. Physiol. Neurobiol. 179:334-337(2011).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH ECE1.
RX   PubMed=26806547; DOI=10.1016/j.biocel.2016.01.016;
RA   Boratko A., Vereb Z., Petrovski G., Csortos C.;
RT   "TIMAP-protein phosphatase 1-complex controls endothelin-1 production via
RT   ECE-1 dephosphorylation.";
RL   Int. J. Biochem. Cell Biol. 73:11-18(2016).
CC   -!- FUNCTION: Regulator of protein phosphatase 1 (PP1) that acts as a
CC       positive regulator of pulmonary endothelial cell (EC) barrier function.
CC       Protects the endothelial barrier from lipopolysaccharide (LPS)-induced
CC       vascular leakage (By similarity). Involved in the regulation of the
CC       PI3K/AKT signaling pathway (By similarity). Involved in the regulation
CC       of angiogenesis and endothelial cell proliferation through the control
CC       of ECE1 dephosphorylation, trafficking and activity (PubMed:26806547).
CC       Involved in the regulation of endothelial cell filopodia extension
CC       (PubMed:17609201). May be a downstream target for TGF-beta1 signaling
CC       cascade in endothelial cells (By similarity). Involved in PKA-mediated
CC       moesin dephosphorylation which is important in EC barrier protection
CC       against thrombin stimulation. Promotes the interaction of PPP1CA with
CC       RPSA/LAMR1 and in turn facilitates the dephosphorylation of RPSA/LAMR1
CC       (By similarity). Involved in the dephosphorylation of EEF1A1 (By
CC       similarity). {ECO:0000250|UniProtKB:Q96T49,
CC       ECO:0000269|PubMed:17609201, ECO:0000269|PubMed:26806547}.
CC   -!- SUBUNIT: Interacts with PPP1CA, PPP1CB and MSN. Interacts (via its
CC       fourth ankyrin repeat) with the mature dimeric form of RPSA/LAMR1.
CC       Interacts with EEF1A1 (By similarity). Interacts with PTEN (By
CC       similarity). Interacts with ECE1 (PubMed:26806547).
CC       {ECO:0000250|UniProtKB:Q96T49, ECO:0000269|PubMed:26806547}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12055102}. Cell
CC       membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Nucleus
CC       {ECO:0000250|UniProtKB:Q96T49}. Cell projection
CC       {ECO:0000250|UniProtKB:Q96T49}. Note=Colocalizes with RPSA/LAMR1 in the
CC       cell membrane (By similarity). Localizes to the perinuclear region
CC       (PubMed:12055102). Colocalizes with PTEN at the tip of EC projections
CC       (By similarity). {ECO:0000250|UniProtKB:Q96T49,
CC       ECO:0000269|PubMed:12055102}.
CC   -!- INDUCTION: Inhibited by TGF-beta1 (PubMed:12055102). Down-regulated by
CC       LPS (PubMed:21907835). {ECO:0000269|PubMed:12055102,
CC       ECO:0000269|PubMed:21907835}.
CC   -!- PTM: Phosphorylated by PKA and, after PKA priming, by GSK3B.
CC       Phosphorylation by GSK3B reduces its association with PP1C and enhances
CC       PP1C activity. Dephosphorylation by its associated PP1C results in
CC       enhanced association with PP1C, but reduced PP1C activity.
CC       {ECO:0000269|PubMed:17609201}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF362909; AAK52795.1; -; mRNA.
DR   RefSeq; NP_777249.1; NM_174824.2.
DR   RefSeq; XP_005214553.1; XM_005214496.3.
DR   AlphaFoldDB; Q95N27; -.
DR   SMR; Q95N27; -.
DR   STRING; 9913.ENSBTAP00000000858; -.
DR   iPTMnet; Q95N27; -.
DR   PaxDb; Q95N27; -.
DR   PRIDE; Q95N27; -.
DR   Ensembl; ENSBTAT00000000858; ENSBTAP00000000858; ENSBTAG00000000653.
DR   GeneID; 282091; -.
DR   KEGG; bta:282091; -.
DR   CTD; 26051; -.
DR   VEuPathDB; HostDB:ENSBTAG00000000653; -.
DR   VGNC; VGNC:33231; PPP1R16B.
DR   eggNOG; KOG0505; Eukaryota.
DR   GeneTree; ENSGT00940000154090; -.
DR   HOGENOM; CLU_000134_54_2_1; -.
DR   InParanoid; Q95N27; -.
DR   OMA; ISPDLCN; -.
DR   OrthoDB; 564568at2759; -.
DR   TreeFam; TF316803; -.
DR   Proteomes; UP000009136; Chromosome 13.
DR   Bgee; ENSBTAG00000000653; Expressed in prefrontal cortex and 101 other tissues.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0017020; F:myosin phosphatase regulator activity; IBA:GO_Central.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IBA:GO_Central.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; IBA:GO_Central.
DR   GO; GO:0061028; P:establishment of endothelial barrier; IBA:GO_Central.
DR   GO; GO:1902309; P:negative regulation of peptidyl-serine dephosphorylation; IEA:Ensembl.
DR   GO; GO:1903589; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IEA:Ensembl.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; IEA:Ensembl.
DR   GO; GO:0051489; P:regulation of filopodium assembly; IMP:UniProtKB.
DR   GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl.
DR   GO; GO:0035304; P:regulation of protein dephosphorylation; IBA:GO_Central.
DR   GO; GO:1903670; P:regulation of sprouting angiogenesis; IMP:UniProtKB.
DR   Gene3D; 1.25.40.20; -; 2.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR017417; Pase-1_reg_su_16AB.
DR   Pfam; PF12796; Ank_2; 2.
DR   PIRSF; PIRSF038159; PP1_16AB_vert; 1.
DR   SMART; SM00248; ANK; 5.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
PE   1: Evidence at protein level;
KW   ANK repeat; Cell membrane; Cell projection; Coiled coil; Lipoprotein;
KW   Membrane; Methylation; Nucleus; Palmitate; Phosphoprotein; Prenylation;
KW   Reference proteome; Repeat.
FT   CHAIN           1..565
FT                   /note="Protein phosphatase 1 regulatory inhibitor subunit
FT                   16B"
FT                   /id="PRO_0000067042"
FT   PROPEP          566..568
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000396709"
FT   REPEAT          100..129
FT                   /note="ANK 1"
FT   REPEAT          133..162
FT                   /note="ANK 2"
FT   REPEAT          228..257
FT                   /note="ANK 3"
FT   REPEAT          261..290
FT                   /note="ANK 4"
FT   REPEAT          531..560
FT                   /note="ANK 5"
FT   REGION          327..346
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          373..404
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          504..525
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          15..55
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        382..404
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         69
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VHQ3"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:17609201"
FT   MOD_RES         337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:17609201"
FT   MOD_RES         350
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T49"
FT   MOD_RES         477
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96T49"
FT   MOD_RES         565
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000250|UniProtKB:Q923M0"
FT   LIPID           564
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q923M0"
FT   LIPID           565
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q923M0"
FT   MUTAGEN         64
FT                   /note="V->A: Hyperphosphorylation, loss of PPP1CA-binding
FT                   and PP1C phosphatase activity; when associated with A-66."
FT                   /evidence="ECO:0000269|PubMed:17609201"
FT   MUTAGEN         66
FT                   /note="F->A: Hyperphosphorylation, loss of PPP1CA-binding
FT                   and PP1C phosphatase activity; when associated with A-64."
FT                   /evidence="ECO:0000269|PubMed:17609201"
FT   MUTAGEN         333
FT                   /note="S->A: Loss of GSK3B-mediated phosphorylation but no
FT                   effect on PKA-mediated phosphorylation. Loss of GSK3B-
FT                   mediated phosphorylation but no effect on PKA-mediated
FT                   phosphorylation; when associated with A-337."
FT                   /evidence="ECO:0000269|PubMed:17609201"
FT   MUTAGEN         337
FT                   /note="S->A: Loss of GSK3B-mediated phosphorylation but no
FT                   effect on PKA-mediated phosphorylation. Loss of GSK3B-
FT                   mediated phosphorylation but no effect on PKA-mediated
FT                   phosphorylation; when associated with A-333."
FT                   /evidence="ECO:0000269|PubMed:17609201"
SQ   SEQUENCE   568 AA;  63643 MW;  61C10899462B0334 CRC64;
     MASHVDLLTE LQLLEKVPTL ERLRAAQKRR AQQLKKWAQY EQDLQHRKRK HERKRSTGGR
     RKKVSFEASV ALLEASLRND AEEVRYFLKN KVSPDLCNED GLTALHQCCI DNFEEIVKLL
     LSHGANVNAK DNELWTPLHA AATCGHINLV KILVQYGADL LAVNSDGNMP YDLCEDEPTL
     DVIETCMAYQ GITQEKINEM RAAPEQQMIS DIHCMIAAGQ DLDWVDAQGA TLLHIAGANG
     YLRAAELLLD HGVRVDVKDW DGWEPLHAAA FWGQMQMAEL LVSHGASLSA RTSMDEMPID
     LCEEEEFKVL LLELKHKHDV IMKSQLRHKS SLSRRTSSAG SRGKVVRRAS LSDRTNLYRK
     EYEGEAILWQ QRSASEDQRN STYNGDIRET RTDQENKDPN PRLEKPVLLS EFPTKIPHSD
     MDMPVENGLR APVSTYQYAL CNGDVWKVHE VPDYSMAYGN PGVADATPSW SGYKEQSPQT
     LLELKRQRAA AKLLSHPFLS THLGSGVSRT GEGSSEGKAP LIGGRTSPYS SNGTSVYYTV
     TSGDPPLLKF KAPIEEMEEK VHGCCRIS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025